New Retinal Physician

10/01/2024

The October issue of Ophthalmic ASC is out today!

08/16/2024

Follow us at Retinal Physician

07/29/2024

An interesting case illustrates how a multidisciplinary approach is essential for accurate diagnosis and management of an asymptomatic cystic lesion with vascular bulbs. Read at: https://ow.ly/sYMu50Stj2X

A multidisciplinary approach is essential for accurate diagnosis and management, particularly in cases where intracranial involvement is suspected. 

07/25/2024

Medical editor Dr. Hemang Pandya discusses mixed attitudes toward PE involvement in health care in this month’s Editor’s Letter. Read at: https://ow.ly/Rnwj50StiXx

Letter from the medical editor.

07/23/2024

An NIH-funded analysis of AREDS and AREDS2 data found that antioxidant supplements can slow the progression of geographic atrophy into the fovea. Read more: https://ow.ly/9aZK50SIutg

An NIH-funded analysis of AREDS and AREDS2 data found that antioxidant supplements can slow the progression of geographic atrophy into the fovea.

07/22/2024

Dr. Kapil Kapoor discusses how his practice has incorporated low-vision wearable technology for patients suffering from central vision loss due to AMD. Read at: https://ow.ly/x0CI50StiCt

Low-vision wearable technology can restore quality of life to many patients suffering from central vision loss due to AMD.

07/20/2024

Alcon’s Unity Vitreoretinal Cataract System (VCS) and Cataract System (CS) receive FDA 510(k) clearance. Read at: https://ow.ly/pmuX50SABAY

07/19/2024

Today at ASRS, Michael Singer, MD, presented late-breaking data on Nanoscope Therapeutics’s multicharacteristic opsin (MCO) optogenetics platform. Read more: https://ow.ly/I1ZH50SGlj3

07/18/2024

This morning at ASRS in Stockholm, Michael Gorin, MD, PhD, presented late-breaking data on the TEASE-3 trial of oral gildeuretinol acetate for disease. Read more: https://ow.ly/UYHp50SFht6

07/17/2024

Data from the RHONE-X extension trial, presented for the first time at ASRS today, showed that faricimab maintained safety and efficacy over 4 years. Read more: https://ow.ly/s7pS50SEHqb

07/17/2024

Drs. Amr Hassan and Mitul Mehta discuss a case where a patient showed improvement in cystoid macular edema secondary to retinitis pigmentosa after taking nutritional supplements. Read at: https://ow.ly/ctag50Stiub

# retinitispigmentosa # cystoidmacularedema

07/15/2024

Flip through the pages of the digital edition, available at: https://ow.ly/yEti50SteMR

07/14/2024

David Boyer, MD, presented ARCHER results highlighting a neuroprotective mechanism of ANX007. Read at: https://ow.ly/FShG50SAB1f

07/13/2024

FDA grants de novo status to Notal Vision’s patient-operated OCT device. Read at: https://ow.ly/JsCK50SAAxw

07/11/2024

In this month’s Practice Management Strategies column, Elizabeth Cifers provides tips on creating a flexible practice culture. Read at: https://ow.ly/E8rm50StimE

07/08/2024

Dr. Basil K. Williams discusses how diversity, equity, and inclusion can improve patient outcomes in ophthalmology. Read at: https://www.newretinalphysician.com/issues/2024/new-retinal-physician-julyaugust/promoting-inclusive-policies-in-ophthalmology-may-improve-patient-outcomes/

07/04/2024

Wishing all of our readers a happy and safe July 4th weekend! And remember, you can help keep your patients and their families safe by spreading awareness around the dangers of fireworks—in fact, according to the Consumer Product Safety commission (CPSC), 16 percent of fireworks injuries were to the eyes. For more information, resources to get the word out to your patients, and ideas for alternatives for safe celebrations, visit https://ow.ly/686K50StjGl.

Fireworks eye injuries can be prevented. There is no safe way for nonprofessionals to use fireworks. Enjoy fireworks only at a professional display​.

07/01/2024

The July/August issue of New Retinal Physician is now available! Read at: newretinalphysician.com